Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP)+, the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Thomas P. Singer*, Rona R. Ramsay, K. McKeown, A. Trevor, N. E. Castagnoli

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

62 Citations (Scopus)

Abstract

It is widely believed that the nigrostriatal toxicity of MPTP is due to its oxidation by brain monoamine oxidase first to MPDP+, and eventually to MPP+. Following uptake by the synaptic dopamine reuptake system, it is concentrated in the matrix of striatal mitochondria by an energy-dependent carrier, energized by the electrical gradient of the membrane. At the very high intramitochondrial concentrations thus reached, MPP+ combines with NADH dehydrogenase at a point distal to its iron-sulfur clusters but prior to the Q10 combining site. This leads to cessation of oxidative phosphorylation, ATP depletion, and cell death. Other pyridine derivatives act similarly on NADH dehydrogenase but they are not acutely toxic unless concentrated by the MPP+ carrier.

Original languageEnglish
Pages (from-to)17-23
Number of pages7
JournalToxicology
Volume49
Issue number1
DOIs
Publication statusPublished - 1 Jan 1988

Keywords

  • MPP
  • MPTP
  • NADH dehydrogenase
  • Neurotoxicity

Fingerprint

Dive into the research topics of 'Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP)+, the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)'. Together they form a unique fingerprint.

Cite this